Activated platelet composition with tunable growth factor level
US-2017362571-A1 · Dec 21, 2017 · US
US11987777B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11987777-B2 |
| Application number | US-202117143659-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 7, 2021 |
| Priority date | Sep 4, 2015 |
| Publication date | May 21, 2024 |
| Grant date | May 21, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems and methods for cell electroporation and molecular delivery using an intelligent, feedback controlled, microscale electroporation system for transfecting single cells.
Opening claim text (preview).
What is claimed is: 1. A method for electroporating a plurality of biological cells, the method comprising: hydrodynamically focusing a continuous flow of a plurality of biological cells into a single-file flow, wherein the single-file flow passes each of the plurality of biological cells through a detection area; generating a cell detection signal; continuously monitoring an impedance value of the detection area; generating, in response to an increase in the impedance value of the detection area over a baseline threshold, a permeabilization signal, the baseline threshold being indicative of a presence of one of the plurality of biological cells within the detection area; stopping the permeabilization signal in response to determining that the impedance value of the detection area is equal to or greater than a permeabilization threshold value; and generating a delivery signal, wherein the delivery signal causes delivery of a molecule into one of the plurality of biological cells focused within the detection area. 2. The method according to claim 1 , further comprising adjusting at least one parameter of the permeabilization signal in response to determining that the impedance value of the detection area is less than the permeabilization threshold value. 3. The method according to claim 1 , further comprising: determining whether the impedance value of the detection area is equal to the permeabilization threshold value; and adjusting at least one parameter of the delivery signal in response to determining the impedance value of the detection area is not equal to the permeabilization threshold value. 4. The method according to claim 3 , further comprising: stopping the delivery signal in response to determining the impedance value of the detection area is one of: less than or equal to a viability threshold, or equal to the baseline threshold. 5. The method according to claim 4 , further comprising stopping the delivery signal in response to at least one of the following: determining that the impedance value is less than the threshold impedance indicating that that the single one of the plurality of biological cells has exited the detection area; or determining that the impedance value is equal to a viability threshold for over-exposure. 6. The method according to claim 1 , wherein the baseline threshold is determined by continuously monitoring the impedance value of a second detection area through which only a buffer solution is flowing. 7. The method according to claim 2 , wherein the at least one parameter of the permeabilization signal is selected from the group of: electric field amplitude, pulse duration, pulse train frequency, duty cycle, and number of cycles. 8. The method according to claim 3 , wherein the at least one parameter of the delivery signal is selected from the group of: electric field amplitude, pulse duration, pulse train frequency, duty cycle, and number of cycles. 9. The method according to claim 1 , wherein the permeabilization threshold value is determined experimentally or using a mathematical model. 10. The method according to claim 1 , wherein the permeabilization threshold value corresponds to an optimal cell permeabilization that does not cause cell death.
Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title
characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title
specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules · CPC title
Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093) · CPC title
Electrical or electromagnetic means, e.g. for electroporation or for cell fusion · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.